期刊文献+

达格列净·(S)-(+)-1,2-丙二醇·一水合物的合成及其有关物质的分离与结构鉴定 被引量:2

Synthesis of Dapagliflozin(S)-(+)-1,2-Propanediol Monohydrate and Separation &Structural Identification of Related Substances
下载PDF
导出
摘要 以4-溴-1-氯-2-(4-乙氧基苄基)苯(2)和2,3,4,6-四-O-三甲基硅基-D-葡萄糖酸内酯(3)为原料,经甲酯化、还原反应、乙酰化保护、精制、水解后与(S)-(+)-1,2-丙二醇和水络合制得达格列净·(S)-(+)-1,2-丙二醇·一水合物(1),总收率为48.2%。对精制步骤所得5的母液,水解后经制备色谱分离纯化,得到2个相关物质:(1S)-1,4-脱水-1-C-[4-氯-3-(4-乙氧基苄基)苯基]-D-葡萄糖醇(6)和(1R)-1,5-脱水-1-C-[4-氯-3-(4-乙氧基苄基)苯基]-D-葡萄糖(7)。产物结构经1H NMR,13C NMR和ESI-MS确认。 Dapagliflozin( S)-( +)-1,2-propanediol monohydrate was synthesized in 48. 2% overall yield from 4-bromo-1-chloro-2-( 4-ethoxybenzyl) benzene( 2) and 2,3,4,6-tetra-O-trimethylsilyl-D-glucono-1,5-lactone( 3) via methyl etherification,reduction,etherification,purified,hydrolysis,complexed with( S)-( +)-1,2-propanediol and water. The mother liquid of 5 from the refining process was hydrolyzed and then purified by chromatography,and two related substances:( 1 S)-1,4-anhydro-1-C-[4-chloro-3-( 4-ethoxybenzyl) phenyl]-D-glucitol( 6) and( 1 R)-1,5-anhydro-1-C-[4-chloro-3-( 4-ethoxybenzyl) phenyl]-D-glucitol( 7) were obtained. The chemical structures were all confirmed by1 H NMR,13 C NMR and ESI-MS.
作者 郑云峰 吴高鑫 罗海荣 Zheng Yunfeng;Wu Gaoxin;Luo Hairong(Zhejiang Hisunpharm Co.,Ltd.,Taizhou 318000,China;School of Material and Chemical Engineering,Tongren University,Tongren 554300,China)
出处 《山东化工》 CAS 2018年第15期48-50,共3页 Shandong Chemical Industry
关键词 达格列净·(S)-(+)-1 2-丙二醇·一水合物 合成 相关物质 分离 结构鉴定 dapagliflozin ( S ) - ( + ) - 1,2 - propanediol monohydrate synthesis related substances separation structural identification
  • 相关文献

参考文献5

二级参考文献40

  • 1Bailey CJ,Gross JL,Pieters A,et al.Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin:a randomized,double-blind,placebocontrolled trial[J].Lancet,2010,375(9733):2223-2233.
  • 2Meng W,Ellsworth BA,Nirschl AA,et al.Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes[J].JMedChem,2008,51 (5):1145-1149.
  • 3Eckhardt M,Eickelmann P,Himmelsbach F,et al.Glucopyranosyl-substituted benzonitrile derivatives,pharmaceutical compositions containing such compounds,their use and process for their manufacture:WO,2007093610[P].2007-08-23.(CA 2007,147:277850).
  • 4Song YL,Chen YW,Cheng HW,et al.Benzylbenzenederivatives and methods of use:WO,2009026537[P].2009-02-26.(CA 2009,150:237833).
  • 5Liou J,Wu YL,Li SB,et al.Processes for the preparation of SGLT2 inhibitors:WO,2010022313[P].2010-02-25.(CA 2010,152:287663).
  • 6ICH. ICH harmonized tripartite guideline,pharmaceutical develop- ment QS[S/OL]. (2009) [2014-03 - 15]. hnp://www, ich. org/products/guidelines, html.
  • 7ICH. ICH harmonized tripartite guideline,quality risk management Q9[S/OL]. (2008) [2014 -03 - 151. http://www, ich. org/ products/guidelines, html.
  • 8ICH. ICH harmonized tripartite guideline, pharmaceutical quality system Q10[S/OL]. (2008) [2014 -03 - 15]. http://www. ich. org/products/guidelines, html.
  • 9PAUL AD, WANG WL, PAUL WS, et al. Clinical relevance of dissolution testing in quality by design [ J 1. AAPS J, 2008, 10 (2) : 380 - 390.
  • 10SIEGFRIED A, DANIELE S, CHARLES R, et al. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation [ J ]. Eur J Pharm Sci, 2011, 42 : 106 - 115.

共引文献71

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部